Author Correction: An in silico approach uncovering the competency of oncolytic human adenovirus 52 for targeted breast cancer virotherapy.
Saved in:
| Title: | Author Correction: An in silico approach uncovering the competency of oncolytic human adenovirus 52 for targeted breast cancer virotherapy. |
|---|---|
| Authors: | Naveed M; Department of Biotechnology, Faculty of Science and Technology, University of Central Punjab, Lahore, 54590, Pakistan. naveed.quaidian@gmail.com., Batool Z; Department of Biotechnology, Faculty of Science and Technology, University of Central Punjab, Lahore, 54590, Pakistan., Aziz T; Laboratory of Animal Health Food Hygiene and Quality, University of Ioannina, Arta, Greece., Javed K; Department of Biotechnology, Faculty of Science and Technology, University of Central Punjab, Lahore, 54590, Pakistan., Ali N; Department of Biotechnology, Faculty of Science and Technology, University of Central Punjab, Lahore, 54590, Pakistan., Rehman HM; School of Biochemistry and Biotechnology, University of the Punjab, Lahore, Pakistan., Alharbi M; Department of Pharmacology and Toxicology College of Pharmacy, King Saud University, Riyadh, Saudi Arabia., Alasmari AF; Department of Pharmacology and Toxicology College of Pharmacy, King Saud University, Riyadh, Saudi Arabia., Alshammari A; Department of Pharmacology and Toxicology College of Pharmacy, King Saud University, Riyadh, Saudi Arabia. iwockd@gmail.com. |
| Source: | Scientific reports [Sci Rep] 2025 Apr 15; Vol. 15 (1), pp. 13000. Date of Electronic Publication: 2025 Apr 15. |
| Publication Type: | Published Erratum |
| Journal Info: | Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE; PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2045-2322 |
|---|---|
| DOI: | 10.1038/s41598-025-97940-1 |